GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer

被引：0
|
作者：
Lilin Wan
Yifan Liu
Ruiji Liu
Weipu Mao
机构：
[1] People’s Hospital of Putuo District,Department of Urology
[2] Affiliated Zhongda Hospital of Southeast University,Department of Urology
[3] Southeast University,Department of Urology, Sichuan Provincial People’s Hospital
[4] School of Medicine,undefined
[5] University of Electronic Science and Technology of China,undefined
来源：
Cancer Cell International | / 23卷
关键词：
GAD1; Prostate cancer; Castration resistant; Drug resistance; Immune;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Catalase as a novel drug target for metastatic castration-resistant prostate cancer
    Giginis, Frantzeska
    Wang, Joshua
    Chavez, Aaron
    Martins-Green, Manuela
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2644 - +
  • [42] PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer
    Wang, Ling-Yu
    Hung, Chiu-Lien
    Wang, Tsan-Chun
    Hsu, Hung-Chih
    Kung, Hsing-Jien
    Lin, Kwang-Huei
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2025, 65 : 375 - 396
  • [43] Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer
    Yang, Xiaobing
    Zhao, Jiahui
    Wei, Dechao
    Feng, Tao
    Guo, Pengju
    Li, Qiankun
    Wang, Yongxing
    Han, Yili
    Li, Mingchuan
    Jiang, Yongguang
    Luo, Yong
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (08) : 760 - 770
  • [44] Variant Allele of HSD3B1 Increases Progression to Castration-Resistant Prostate Cancer
    Wu, Gang
    Huang, Shengsong
    Nastiuk, Kent L.
    Li, Jinliang
    Gu, Jun
    Wu, Ming
    Zhang, Qimin
    Lin, Hanqing
    Wu, Denglong
    PROSTATE, 2015, 75 (07) : 777 - 782
  • [45] Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    Szarvas, Tibor
    Sevcenco, Sabina
    Modos, Orsolya
    Keresztes, David
    Nyirady, Peter
    Kubnik, Andras
    Romics, Miklos
    Kovalszky, Ilona
    Reis, Henning
    Hadaschik, Boris
    Shariat, Shahrokh F.
    Kramer, Gero
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 312.e9 - 312.e15
  • [46] Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
    Galletti, Giuseppe
    Leach, Benjamin I.
    Lam, Linda
    Tagawa, Scott T.
    CANCER TREATMENT REVIEWS, 2017, 57 : 16 - 27
  • [47] Castration resistance mechanisms in prostate cancer
    Martinez-Breijo, Sara
    Chantada-Abal, Venancio
    Aller-Rodriguez, Marcos
    Bohorquez-Cruz, Manuel
    Sacristan-Lista, Felipe
    Ponce-Diaz, Jose
    Vazquez-Martul, Dario
    Lamas-Diaz, Leticia
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (08): : 628 - 638
  • [48] SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression
    Wang, Hongtao
    Wu, Ruiqin
    Yu, Lan
    Wu, Feima
    Li, Shanhu
    Zhao, Yali
    Li, Hailiang
    Luo, Guolan
    Wang, Jian
    Zhou, Jianguang
    ONCOLOGY REPORTS, 2012, 28 (04) : 1468 - 1474
  • [49] Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2
    Siddique, Abu Bakar
    Ebrahim, Hassan Y.
    Tajmim, Afsana
    King, Judy Ann
    Abdelwahed, Khaldoun S.
    Abd Elmageed, Zakaria Y.
    El Sayed, Khalid A.
    CANCERS, 2022, 14 (14)
  • [50] Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
    Liu, Hsin-Ho
    Tsai, Yuh-Shyan
    Lai, Chen-Li
    Tang, Chih-Hsin
    Lai, Chih-Ho
    Wu, Hsi-Chin
    Hsieh, Jer-Tsong
    Yang, Che-Rei
    BIOMEDICINE-TAIWAN, 2014, 4 (01): : 7 - 15
12345